Abstract
Lung cancer is the most frequently occurring cancer in the world, and in the United States it is the second most common cancer diagnosed. Accurate staging by imaging can have a significant impact on appropriate treatment and surgical options. Familiarity with the different histologic subtypes of lung cancer and the typical and atypical appearances of lung cancer is vital. Radiologists serve a critical role in the diagnosis, staging, and follow-up of patients with lung cancer.
MeSH terms
-
Aged
-
Aged, 80 and over
-
Biopsy
-
Carcinoma, Non-Small-Cell Lung / diagnosis*
-
Carcinoma, Non-Small-Cell Lung / diagnostic imaging
-
Carcinoma, Non-Small-Cell Lung / pathology
-
Carcinoma, Small Cell / diagnosis*
-
Carcinoma, Small Cell / diagnostic imaging
-
Carcinoma, Small Cell / pathology
-
Diagnosis, Computer-Assisted
-
Female
-
Fluorodeoxyglucose F18
-
Follow-Up Studies
-
Humans
-
Incidence
-
Lung / pathology
-
Lung Neoplasms / diagnosis*
-
Lung Neoplasms / diagnostic imaging
-
Lung Neoplasms / epidemiology
-
Lung Neoplasms / mortality
-
Lung Neoplasms / pathology
-
Lymphatic Metastasis / diagnosis
-
Magnetic Resonance Imaging
-
Male
-
Mediastinum
-
Middle Aged
-
Neoplasm Staging
-
Positron-Emission Tomography*
-
Radiography, Thoracic*
-
Radiopharmaceuticals
-
Risk Factors
-
Sex Factors
-
Time Factors
-
Tomography, X-Ray Computed*
Substances
-
Radiopharmaceuticals
-
Fluorodeoxyglucose F18